Herein, we demonstrate that Fe2O3 nanorod photoanodes modified with P-doping and a MnO2 oxygen evolution cocatalyst exhibited a remarkably enhanced PEC water oxidation activity.
The selectively integrating electron and hole transfer layers into hematite reduce surface and interface recombination for PEC water splitting performance.
Surface recombination is a critical
issue for tantalum nitride
(Ta3N5)-based photoanodes in solar water splitting
application. The efficient cocatalysts (Ni-, Fe-, and Co-based) have
been developed to promote the electron–hole separation and
transportation but still have limited success in some cases. Herein,
we studied the Ar plasma-induced etching strategy on the pristine
Ta3N5 nanotubes and Co(OH)
x
-decorated Ta3N5 nanotubes. The Ar plasma
can not only destroy the recombination center (TaO) in the interface
between the Ta3N5 and electrolyte, resulting
in a fast charge transfer, but also most importantly generate more
oxygen vacancies with a high ratio of Co2+/Co3+ and produce a higher surface area in the Co(OH)
x
cocatalyst. The more active sites on Ta3N5 and abundant oxygen vacancies on cocatalyst synergetically contribute
to the enhanced solar water splitting activity, which give rise to
a fast water oxidation reaction in the interface. The resulting photoanode
shows double the performance improvement under AM 1.5G sunlight conditions.
Interface-defect engineering is proven to be an efficient and facile
strategy to enhance the solar water oxidation activity of Ta3N5, which highlights the advantages of the plasma-etching
strategy for establishing the highly active cocatalysts on photoanodes
in terms of the conversion of solar energy into chemical energy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.